Enliven Therapeutics, Inc. Price (ELVN)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

47,072,532

(32.4263)%

news-img

Cash Flow Statement

Enliven Therapeutics, Inc.

Currency: USD

YEAR 2017 2018 2019 2020 2021 2022 2023 2024
Operating Activities
Net Income 0.00

+0%

-11,337,000.00

+0%

-23,463,000.00

+107%

-18,966,000.00

-19%

-24,740,000.00

+30%

-37,662,000.00

+52%

-71,584,000.00

+90%

-89,024,000.00

+24%

Depreciation And Amortiz... 0.00 0.00 33.00k 45.00k 115.00k 215.00k 297.00k 317.00k
Deferred Income Tax 0.00 0.00 -215,000.00 0.00 -3,809,000.00 0.00 0.00 0.00
Stock-Based Compensat... 0.00 555.00k 899.00k 130.00k 1.92M 3.19M 12.91M 20.17M
Change In Working Capital
Accounts Receivables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payables -666,000.00 477.00k 750.00k 291.00k 1.73M 411.00k -2,250,000.00 810.00k
Inventory 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Working Capital 478.00k 758.00k -77,000.00 292.00k 1.83M 27.00k 3.65M -5,351,000.00
Other Non-Cash Items -7,931,000.00 848.00k 196.00k 9.68M 3.81M 1.74M -4,297,000.00 -118,000.00
Net Cash Provided By Op... -8,785,000.00

+0%

-8,777,000.00

0%

-21,877,000.00

+149%

-8,529,000.00

-61%

-19,134,000.00

+124%

-32,077,000.00

+68%

-61,269,000.00

+91%

-73,192,000.00

+19%

Investing Activities
Investments In Propert... 0.00 0.00 -140,000.00 -461,000.00 -191,000.00 -612,000.00 -149,000.00 -44,000.00
Acquisitions Net 0.00 0.00 0.00 0.00 0.00 35.00M 0.00 0.00
Purchases Of Investments 0.00 0.00 -23,920,000.00 -64,203,000.00 -47,557,000.00 -35,000,000.00 -268,263,000.00 -350,740,000.00
Sales Maturities Of Inve... 0.00 0.00 0.00 47.50M 45.94M 41.88M 120.00M 313.91M
Other Investing Activities 0.00 0.00 0.00 16.70M 1.62M -41,878,000.00 0.00 873.00k
Net Cash Used For Inv... 0.00

+0%

0.00

+0%

-24,060,000.00

+0%

-461,000.00

-98%

-191,000.00

-59%

-612,000.00

+220%

-148,412,000.00

+24,150%

-35,997,000.00

-76%

Financing Activities
Debt Repayment 0.00 0.00 -1,996,000.00 0.00 0.00 0.00 0.00 0.00
Common Stock Issued 11.00M 6.49M 45.58M 140.00k 690.00k 591.00k 161.20M 39.19M
Common Stock Repurch... 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividends Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Financing Activities 11.00M 6.49M 0.00 260.89M -1,242,000.00 -1,799,000.00 234.29M 93.98M
Net Cash Used/Provide... 11.00M

+0%

6.49M

-41%

43.58M

+572%

130.51M

+199%

-1,016,000.00

-101%

-1,799,000.00

+77%

234.29M

-13,123%

133.17M

-43%

Effect Of Forex Changes... 0.00 0.00 -88,000.00 0.00 0.00 74.20M 0.00 0.00
Net Change In Cash 2.22M -2,289,000.00 -2,446,000.00 121.52M -20,341,000.00 -34,488,000.00 24.61M 23.98M
Cash At Beginning Of Per... 7.46M 9.67M 7.38M 8.90M 130.42M 110.08M 75.59M 100.20M
Cash At End Of Period 9.67M 7.38M 4.94M 130.42M 110.08M 75.59M 100.20M 124.17M
Additional Metrics:
Operating Cash Flow -8,785,000.00 -8,777,000.00 -21,877,000.00 -8,529,000.00 -19,134,000.00 -32,077,000.00 -61,269,000.00 -73,192,000.00
Capital Expenditure 0.00 0.00 -140,000.00 -461,000.00 -191,000.00 -612,000.00 -149,000.00 -44,000.00
Free Cash Flow -8,785,000.00

+0%

-8,777,000.00

0%

-22,017,000.00

+151%

-8,990,000.00

-59%

-19,325,000.00

+115%

-32,689,000.00

+69%

-61,418,000.00

+88%

-73,236,000.00

+19%

8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation